GSK256073 tris is a selective and orally bioavailable agonist of GPR109A (HCA2), exhibiting a high potency with a pEC50 of 7.5 in human models. This compound acutely enhances glucose homeostasis through the inhibition of lipolysis, making it a valuable tool for research related to type 2 diabetes mellitus (T2DM) and dyslipidemia. Its long-lasting effect and non-flushing profile provide significant utility in metabolic disorder investigations.
GSK256073 tris is a selective and orally bioavailable agonist of GPR109A (HCA2), exhibiting a high potency with a pEC50 of 7.5 in human models. This compound acutely enhances glucose homeostasis through the inhibition of lipolysis, making it a valuable tool for research related to type 2 diabetes mellitus (T2DM) and dyslipidemia. Its long-lasting effect and non-flushing profile provide significant utility in metabolic disorder investigations.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
